MARC보기
LDR01770nam u200505 4500
001000000468411
00520220223113549
008220131s2021 us ||||||||||||||c||eng d
020 ▼a 9798534680355
035 ▼a (MiAaPQ)AAI28496885
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 247004
0820 ▼a 614.4
1001 ▼a Shin, HoJin. ▼0 (orcid)0000-0002-2032-6134.
24510 ▼a Evaluating Novel Glucose-Lowering Therapies in First-Line Treatment for Type 2 Diabetes.
260 ▼a [S.l.]: ▼b Harvard University., ▼c 2021.
260 1 ▼a Ann Arbor: ▼b ProQuest Dissertations & Theses, ▼c 2021.
300 ▼a 121 p.
500 ▼a Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
500 ▼a Advisor: Scheneeweiss, Sebastian.
5021 ▼a Thesis (Ph.D.)--Harvard University, 2021.
506 ▼a This item must not be sold to any third party vendors.
590 ▼a School code: 0084.
650 4 ▼a Epidemiology.
650 4 ▼a Databases.
650 4 ▼a Socioeconomic factors.
650 4 ▼a Human immunodeficiency virus--HIV.
650 4 ▼a Acquired immune deficiency syndrome--AIDS.
650 4 ▼a Trends.
650 4 ▼a Mortality.
650 4 ▼a Obesity.
690 ▼a 0766
71020 ▼a Harvard University. ▼b Population Health Sciences.
7730 ▼t Dissertations Abstracts International ▼g 83-02B.
773 ▼t Dissertation Abstract International
790 ▼a 0084
791 ▼a Ph.D.
792 ▼a 2021
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T16052020 ▼n KERIS ▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다.
980 ▼a 202202 ▼f 2022
990 ▼a ***1012033
991 ▼a E-BOOK